Telman Deborah H 4
4 · GILEAD SCIENCES, INC. · Filed Sep 11, 2025
Insider Transaction Report
Form 4
Telman Deborah H
EVP, Corporate Affairs & GC
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-09-10−1,315→ 20,331 total→ Common Stock (1,315 underlying) - Exercise/Conversion
Common Stock
2025-09-10+1,315→ 44,036 total - Tax Payment
Common Stock
2025-09-10$115.25/sh−634$73,069→ 43,402 total
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.